Paper40161350
MicroRNA-99 family in cancer: molecular mechanisms for clinical applications.
Wang Y and 3 others. PeerJ, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. MicroRNA-99 family in cancer: molecular mechanisms for clinical applications. Papers, record 40161350. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40161350
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Neoplasms | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Humans | |
| Apoptosis | |
| Biomarkers, Tumor | |
| Carcinogenesis |
Source PubMed
References255
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30903488 | Changes in the Metastatic Properties of MDA-MB-231 Cells after IGFBP6 Gene Knockdown Is Associated with Increased Expression of miRNA Genes Controlling INSR, IGF1R, and CCND1 Genes. | Bull Exp Biol Med | 2019 | https://conductscience.org/library/papers/30903488 | PubMed |
| 2 | 18774294 | The let-7 family of microRNAs. | Trends Cell Biol | 2008 | https://conductscience.org/library/papers/18774294 | PubMed |
| 3 | 37582734 | Serum lncRNA THRIL predicts benign and malignant pulmonary nodules and promotes the progression of pulmonary malignancies. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37582734 | PubMed |
| 4 | 27158394 | Tumor-suppressive miR-99a inhibits cell proliferation via targeting of TNFAIP8 in osteosarcoma cells. | Am J Transl Res | 2016 | https://conductscience.org/library/papers/27158394 | PubMed |
| 5 | 30981762 | MicroRNA-125 in immunity and cancer. | Cancer Lett | 2019 | https://conductscience.org/library/papers/30981762 | PubMed |
| 6 | 29035371 | lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling. | Nat Med | 2017 | https://conductscience.org/library/papers/29035371 | PubMed |
| 7 | 28642484 | miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer. | Sci Rep | 2017 | https://conductscience.org/library/papers/28642484 | PubMed |
| 8 | 27081843 | Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone. | Mol Med Rep | 2016 | https://conductscience.org/library/papers/27081843 | PubMed |
| 9 | 32911741 | Negative Regulation of Serine Threonine Kinase 11 (STK11) through miR-100 in Head and Neck Cancer. | Genes (Basel) | 2020 | https://conductscience.org/library/papers/32911741 | PubMed |
| 10 | 20484036 | Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. | Cancer Res | 2010 | https://conductscience.org/library/papers/20484036 | PubMed |
| 11 | 31164632 | The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31164632 | PubMed |
| 12 | 36764156 | Genomic instability-related twelve-microRNA signatures for predicting the prognosis of gastric cancer. | Comput Biol Med | 2023 | https://conductscience.org/library/papers/36764156 | PubMed |
| 13 | 35720506 | miR-99a-5p inhibits glycolysis and induces cell apoptosis in cervical cancer by targeting RRAGD. | Oncol Lett | 2022 | https://conductscience.org/library/papers/35720506 | PubMed |
| 14 | 32152275 | HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32152275 | PubMed |
| 15 | 33198772 | Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression. | J Exp Clin Cancer Res | 2020 | https://conductscience.org/library/papers/33198772 | PubMed |
| 16 | 22167321 | Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway. | Breast Cancer Res Treat | 2012 | https://conductscience.org/library/papers/22167321 | PubMed |
| 17 | 27748936 | miR-100 resensitizes resistant epithelial ovarian cancer to cisplatin. | Oncol Rep | 2016 | https://conductscience.org/library/papers/27748936 | PubMed |
| 18 | 37184125 | Downregulation of miR-100-5p in cancer-associated fibroblast-derived exosomes facilitates lymphangiogenesis in esophageal squamous cell carcinoma. | Cancer Med | 2023 | https://conductscience.org/library/papers/37184125 | PubMed |
| 19 | 24805183 | Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2. | Int J Oncol | 2014 | https://conductscience.org/library/papers/24805183 | PubMed |
| 20 | 29296717 | Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia. | Blood Adv | 2017 | https://conductscience.org/library/papers/29296717 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42481967 | Non-invasive diagnostic evaluation of urinary exosomal let-7c cluster expression in bladder cancer using machine learning approaches. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42481967 | PubMed |
| 42100432 | miR-99b-5p inhibition drives apoptosis and tumor shrinkage in triple-negative breast cancer: functional characterization through AGO2-RIP-seq and mechanistic insights. | Front Oncol | 2026 | https://conductscience.org/library/papers/42100432 | PubMed |
| 42064128 | Expression profile of miR-99a and miR-218 across oral submucous fibrosis and oral squamous cell carcinoma. | J Oral Maxillofac Pathol | 2026 | https://conductscience.org/library/papers/42064128 | PubMed |
| 41096589 | Stefin A Regulation of Cathepsin B Expression and Localization in Cancerous and Non-Cancerous Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096589 | PubMed |
| 40641110 | MicroRNA‑21: A potential therapeutic target in lung cancer (Review). | Int J Oncol | 2025 | https://conductscience.org/library/papers/40641110 | PubMed |
| 40462168 | The lncrna HMMR-AS1 promotes the malignant progression of ovarian cancer cells by regulating the miR-627-3p/PTN axis. | J Ovarian Res | 2025 | https://conductscience.org/library/papers/40462168 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MIR100 | 406892 | PubTator's text mining | https://conductscience.org/library/genes/406892 | NCBI Gene |
| MIR99A | 407055 | PubTator's text mining | https://conductscience.org/library/genes/407055 | NCBI Gene |
| MIR99B | 407056 | PubTator's text mining | https://conductscience.org/library/genes/407056 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40161350
GET https://conductscience.org/api/papers/v1/40161350/references?page=2